{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:15:50Z","timestamp":1778883350806,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA050330"],"award-info":[{"award-number":["U01DA050330"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["10501556"],"award-info":[{"award-number":["10501556"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["9957332"],"award-info":[{"award-number":["9957332"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["9758593"],"award-info":[{"award-number":["9758593"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014452","name":"College of Medicine, University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrep.2025.102243","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:45:12Z","timestamp":1757522712000},"page":"102243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective real-time disulfide reduction with simultaneous fluorescent labeling of a humanized anti-cocaine mAb"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6211-1414","authenticated-orcid":false,"given":"Terence L.","family":"Kirley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-5773","authenticated-orcid":false,"given":"Andrew B.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102243_bib1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/dmd.114.057034","article-title":"A recombinant humanized anti-cocaine monoclonal antibody inhibits the distribution of cocaine to the brain in rats","volume":"42","author":"Norman","year":"2014","journal-title":"Drug Metabol. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.bbrep.2025.102243_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.drugalcdep.2016.09.024","article-title":"The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats","volume":"168","author":"Wetzel","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbrep.2025.102243_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbrc.2017.04.117","article-title":"Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate","volume":"487","author":"Wetzel","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2025.102243_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/tbcr-25-2","article-title":"Escalation and optimisation of primary breast cancer treatment with antibody-drug conjugates","volume":"6","author":"Toi","year":"2025","journal-title":"Transl. Breast Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102243_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.103012","article-title":"Combining antibody-drug conjugates with immune checkpoint inhibitors: a new paradigm for breast cancer therapy","volume":"140","author":"Xu","year":"2025","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bbrep.2025.102243_bib6","first-page":"362","article-title":"Advancements in antibody-drug conjugates as cancer therapeutics","volume":"5","author":"Fong","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.bbrep.2025.102243_bib7","first-page":"34","article-title":"The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy","volume":"8","author":"Zhou","year":"2025","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bbrep.2025.102243_bib8","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1039\/D1SC02973H","article-title":"Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates","volume":"12","author":"Kang","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bbrep.2025.102243_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/acs.bioconjchem.1c00213","article-title":"Cysteine-based coupling: challenges and solutions","volume":"32","author":"You","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbrep.2025.102243_bib10","article-title":"Characterization and optimization of fluorescein isothiocyanate labeling of humanized h2E2 anti-cocaine mAb","volume":"35","author":"Kirley","year":"2023","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2025.102243_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0076-6879(90)84268-L","article-title":"Protein biotinylation","volume":"184","author":"Bayer","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrep.2025.102243_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-420070-8.00010-6","article-title":"Protein biotinylation","volume":"536","author":"Alegria-Schaffer","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrep.2025.102243_bib13","article-title":"Decreased solubility and increased adsorptivity of a biotinylated humanized anti-cocaine mAb","author":"Kirley","year":"2024","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrep.2025.102243_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-416039-2.00006-9","article-title":"Conjugation of anticancer drugs through endogenous monoclonal antibody cysteine residues","volume":"502","author":"Lyon","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrep.2025.102243_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9654-4_1","article-title":"Site-specific conjugation of thiol-reactive cytotoxic agents to nonnative cysteines of engineered monoclonal antibodies","volume":"2033","author":"Dickgiesser","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrep.2025.102243_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/acs.bioconjchem.5b00626","article-title":"Specific conjugation of the Hinge region for homogeneous preparation of antibody fragment-drug conjugate: a case study for Doxorubicin-PEG-anti-CD20 fab' synthesis","volume":"27","author":"Zhou","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbrep.2025.102243_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149362","article-title":"Novel partial reduction of the humanized anti-cocaine mAb h2E2 for selective cysteine labeling","volume":"692","author":"Kirley","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2025.102243_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0003-2697(89)90422-3","article-title":"Reduction and fluorescent labeling of cyst(e)ine-containing proteins for subsequent structural analyses","volume":"180","author":"Kirley","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrep.2025.102243_bib19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1021\/ac00277a044","article-title":"New fluorogenic reagent having halogenobenzofurazan structure for thiols: 4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole","volume":"56","author":"Toyo'oka","year":"1984","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrep.2025.102243_bib20","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1021\/ac00286a032","article-title":"Isolation and characterization of cysteine-containing regions of proteins using 4-(Aminosulfonyl)-7-2,1,3-benzoxadiazole and high-performance liquid chromatography","volume":"57","author":"Toyo'oka","year":"1985","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrep.2025.102243_bib21","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1016\/S0021-9258(18)83219-7","article-title":"Determination of three disulfide bonds and one free sulfhydryl in the b subunit of (Na,K)-ATPase","volume":"264","author":"Kirley","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.102243_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature (London)"},{"key":"10.1016\/j.bbrep.2025.102243_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijbiomac.2019.08.066","article-title":"Agarose native gel electrophoresis of proteins","volume":"140","author":"Li","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrep.2025.102243_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijbiomac.2020.02.185","article-title":"Agarose native gel electrophoresis for characterization of antibodies","volume":"151","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrep.2025.102243_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijbiomac.2021.01.075","article-title":"Analysis of protein denaturation, aggregation and post-translational modification by agarose native gel electrophoresis","volume":"172","author":"Sakuma","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrep.2025.102243_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112676","article-title":"A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics","volume":"476","author":"Kirley","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrep.2025.102243_bib27","article-title":"Isothermal titration calorimetry determination of thermodynamics of binding of cocaine and its metabolites to humanized h2E2 anti-cocaine mAb","volume":"32","author":"Kirley","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2025.102243_bib28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.xphs.2023.03.019","article-title":"Reformulation and thermal stability of a therapeutic anti-cocaine mAb","volume":"112","author":"Kirley","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrep.2025.102243_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0003-2697(02)00650-4","article-title":"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole is not specific for labeling of sulfhydryl groups in proteins as it may also react with phenolic hydroxyl groups and amino groups","volume":"314","author":"Husted","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrep.2025.102243_bib30","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic fluorescent dyes as tools for protein characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbrep.2025.102243_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/1087057116646553","article-title":"Simultaneous high-throughput conformational and colloidal stability screening using a fluorescent molecular rotor dye, 4-(4-(Dimethylamino)styryl)-N-Methylpyridinium iodide (DASPMI)","volume":"21","author":"Wong","year":"2016","journal-title":"J. Biomol. Screen"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825003309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825003309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:45:54Z","timestamp":1778881554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825003309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S2405580825003309"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102243","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective real-time disulfide reduction with simultaneous fluorescent labeling of a humanized anti-cocaine mAb","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102243"}}